.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
US Army
Novartis
McKinsey
Julphar
Daiichi Sankyo
Johnson and Johnson
Dow
Federal Trade Commission
AstraZeneca

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204822

« Back to Dashboard
NDA 204822 describes IZBA, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge. Additional details are available on the IZBA profile page.

The generic ingredient in IZBA is travoprost. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the travoprost profile page.

Summary for NDA: 204822

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrength0.003% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:May 15, 2014TE:RLD:Yes
Patent:8,178,582Patent Expiration:Oct 10, 2029Product Flag?YSubstance Flag?Delist Request?
Patent:8,722,735Patent Expiration:Oct 10, 2029Product Flag?YSubstance Flag?Delist Request?
Patent:8,754,123Patent Expiration:May 19, 2029Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Moodys
Mallinckrodt
US Department of Justice
Daiichi Sankyo
Chinese Patent Office
AstraZeneca
Colorcon
Medtronic
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot